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Abstract: Malaysia is an endemic hot spot for melioidosis; however, a comprehensive picture of
the burden of disease, clinical presentations, and challenges faced in diagnosis and treatment of
melioidosis is not available. This review provides a nonexhaustive overview of epidemiological
data, clinical studies, risk factors, and mortality rates from available literature and case reports.
Clinical patterns of melioidosis are generally consistent with those from South and Southeast Asia in
terms of common primary presentations with diabetes as a major risk factor. Early diagnosis and
appropriate management of Malaysian patients is a key limiting factor, which needs to be addressed
to reduce serious complications and high mortality and recurrence rates. Promoting awareness
among the local healthcare personnel is crucial to improving diagnostics and early treatment, as
well as educating the Malaysian public on disease symptoms and risk factors. A further matter of
urgency is the need to make this a notifiable disease and the establishment of a national melioidosis
registry. We also highlight local studies on the causative agent, Burkholderia pseudomallei, with regards
to bacteriology and identification of virulence factors as well as findings from host–pathogen
interaction studies. Collectively, these studies have uncovered new correlations and insights for
further understanding of the disease.
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